Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

VRTXNASDAQ

Vertex Pharmaceuticals is a biotechnology company in the healthcare sector on NASDAQ, led by Reshma Kewalramani, with a market cap of $116.04B. As of Q3 2025, 90% of shares are held by 1,474 institutional investors, with Capital World Investors as the largest holder at 10.11%.

President and Chief Executive OfficerReshma Kewalramani
Market Cap$116.04B
Biotechnology
Healthcare
Employees5.4K
Websitevrtx.com
Country
United States of America

Overview

Overview of institutional ownership in VRTX as of Q3 2025 with a market cap of $100.41B

All Institutions

Institutions
1,474
Value Held
$90.3B
Shares Held
231.0M
Avg Position
$61.3M
Median Position
$1.1M

Hedge Funds

Hedge Funds
70
Value Held
$1.3B
Shares Held
3.4M
Avg Position
$19.1M
Median Position
$3.0M

Ownership Breakdown

Institutional (non-HF): 88.61%Institutional (non-HF)Hedge Funds: 1.33%Retail & Other: 10.06%Retail & Other
Institutional (non-HF)
88.61%
$89.0B
Hedge Funds
1.33%
$1.3B
Retail & Other
10.06%
$10.1B

Based on market cap of $100.41B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in VRTX as of Q3 2025

InstitutionPosition Value
$10.1B
1.39% of portfolio
$9.5B
0.14% of portfolio
B
BlackRock, Inc.
Institution
$8.7B
0.15% of portfolio
$6.5B
1.22% of portfolio
$4.5B
0.16% of portfolio
$2.5B
0.16% of portfolio
$2.3B
0.15% of portfolio
$1.9B
0.33% of portfolio
$1.8B
0.30% of portfolio
ALLIANCEBERNSTEIN L.P. logo
ALLIANCEBERNSTEIN L.P.
Long Only Manager
$1.8B
0.56% of portfolio

Net Capital Flow

Institutional buying and selling activity for VRTX in Q3 2025

Net Flow
$2.6B
Buyers
559
Sellers
751
Total Bought
+$4.7B
Total Sold
$7.3B
Avg Position
$59.4M

Biggest Buyers

InstitutionNet Bought
+$804.2M
+2.1M shares
+$437.8M
+1.1M shares
+$221.4M
+565.4K shares
+$204.0M
+520.9K shares
+$174.3M
+445.0K shares
S
Squarepoint Ops LLC
Hedge FundQuant
+$169.2M
+432.1K shares
B
BlackRock, Inc.
Institution
+$149.3M
+381.1K shares
+$130.6M
+336.6K shares
+$125.2M
+319.7K shares
LOOMIS SAYLES & CO L P logo
LOOMIS SAYLES & CO L P
Long Only Manager
+$120.9M
+308.8K shares

Biggest Sellers

InstitutionNet Sold
FMR LLC logo
FMR LLC
Institution
$1.2B
3.1M shares
$1.1B
2.8M shares
JENNISON ASSOCIATES LLC logo
JENNISON ASSOCIATES LLC
Long Only Manager
$1.1B
2.7M shares
EDGEWOOD MANAGEMENT LLC logo
EDGEWOOD MANAGEMENT LLC
Long Only Manager
$378.9M
967.4K shares
$305.9M
781.2K shares
$289.5M
650.3K shares
$196.0M
500.4K shares
$175.1M
447.1K shares
$108.4M
276.8K shares
$105.4M
269.0K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited VRTX in Q3 2025

New Positions
46
New Value
$74.4M
Exited Positions
156
Exited Value
$750.9M

New Positions

InstitutionPosition Value
F
Freestone Grove Partners LP
Hedge FundMulti-Strategy
$43.2M
110.3K shares
$6.0M
15.2K shares
$5.0M
12.8K shares
$4.5M
10.7K shares
A
ADAR1 Capital Management, LLC
Hedge FundLong/Short
$2.7M
7.0K shares
$2.1M
5.4K shares
$1.4M
3.6K shares
NLI INTERNATIONAL INC logo
NLI INTERNATIONAL INC
Insurance Manager
$1.1M
2.8K shares
$955.6K
2.4K shares
$886.4K
2.1K shares

Exited Positions

InstitutionPrevious Position
$289.5M
650.3K shares
ORBIMED ADVISORS LLC logo
ORBIMED ADVISORS LLC
Hedge FundSector
$93.6M
210.3K shares
A
AXA
Institution
$76.2M
171.3K shares
$68.7M
154.2K shares
$39.0M
87.5K shares
$31.6M
71.0K shares
$23.3M
52.4K shares
$21.7M
48.8K shares
$10.1M
22.6K shares
$8.0M
18.0K shares

Options Activity

Institutions with the largest Call and Put options positions in VRTX as of Q3 2025

Call Positions
36
Call Value
$715.2M
Put Positions
37
Put Value
$471.4M

Call Positions

InstitutionPosition Value
$233.7M
6.0K contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$107.9M
2.8K contracts
$56.8M
1.5K contracts
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$51.1M
1.3K contracts
$40.4M
1.0K contracts
Centiva Capital, LP logo
Centiva Capital, LP
Hedge FundMulti-Strategy
$39.2M
1.0K contracts
$19.0M
485.0 contracts
$17.9M
456.0 contracts
UBS Group AG logo
UBS Group AG
Institution
$15.3M
391.0 contracts
$14.5M
369.0 contracts

Put Positions

InstitutionPosition Value
$135.5M
3.5K contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$53.3M
1.4K contracts
$25.5M
651.0 contracts
$22.2M
567.0 contracts
UBS Group AG logo
UBS Group AG
Institution
$21.7M
553.0 contracts
$21.5M
544.0 contracts
$21.0M
536.0 contracts
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$19.6M
501.0 contracts
T
Twin Tree Management, LP
Hedge FundVol Arbitrage
$18.3M
466.0 contracts
P
PEAK6 LLC
Institution
$17.0M
433.0 contracts

Most Committed Institutions

Institutions with VRTX as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
S
5.30%
$60.1M
BRIDGER MANAGEMENT, LLC logo
BRIDGER MANAGEMENT, LLC
Hedge FundLong/Short
4.29%
$7.4M
B
4.13%
$198.1M
A
Artia Global Partners LP
Hedge FundLong/Short
3.80%
$21.6M
Sivik Global Healthcare LLC logo
Sivik Global Healthcare LLC
Hedge FundLong/Short
2.97%
$5.5M
2.86%
$738.7K
S
Sofinnova Ventures Inc
Venture Capital
2.83%
$46.2M
2.81%
$54.8M
S
2.61%
$10.3M
2.58%
$13.0M

Hedge Fund Spotlight

Discover hedge funds investing in VRTX

A
Artia Global Partners LP
Hedge FundLong/Short
Portfolio ManagerOnusa Nmn Chantanapongwanij
Portfolio Value
$568.3M
Positions
48
Last Reported
Q3 2025
AddressMiami, FL
Sector Allocation
Healthcare: 70.60%HealthcareFinancial Services: 0.30%
Vertex Pharmaceuticals logo

Position in Vertex Pharmaceuticals

Market Value
$21.6M
Shares Held
55.1K
Portfolio Weight
3.80%
Owned Since
2025-Q2
Top HoldingSectorMarket ValueWeight
1
Insmed logo
Insmed
INSM
Biotechnology
Healthcare
$105.4M18.55%
2
ARGX
argenx
ARGX
Unknown
Unknown
$57.8M10.16%
Biotechnology
Healthcare
$45.4M8.00%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.